RxDoctor Payments Data

Adam Burow, DO

Interventional Cardiology · Fort Myers, FLNPI 1487035705

Payments from drug & device makers

$5,185in general payments, 2019–2025

Across 51 payments — averaging $101.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Abbott$1K
  • Boston Scientific$443
  • Philips North America LLC$164
  • Siemens Medical Solutions USA, Inc.$120
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$98
  • plus $328 from 10 others

What the payments were for

  • Grants$2,60050%
  • Food & beverage$2,27544%
  • Education$3106%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,185 in reported general payments places this provider in the 30th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$867,309
Medicare patients
2,037
Services billed
5,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban156$226,075
XareltoRivaroxaban60$52,683
MultaqDronedarone Hcl28$33,985
EntrestoSacubitril/Valsartan18$21,196
Repatha SureclickEvolocumab22$17,004
JardianceEmpagliflozin21$14,875
Metoprolol Succinate192$2,985
ClopidogrelClopidogrel Bisulfate195$2,802
Bisoprolol Fumarate29$1,331
Atorvastatin Calcium108$1,025
Ranolazine ErRanolazine12$990
Amlodipine Besylate119$925
Rosuvastatin Calcium71$923
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$901
Isosorbide Mononitrate ErIsosorbide Mononitrate73$766

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$35$226,075156 claims
Johnson & JohnsonXarelto$20$52,68360 claims
NovartisEntresto$52$21,19618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 623 interventional cardiology providers in Florida.

Other interventional cardiology in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →